In Ng’s view, the high valuations of healthcare stocks are due to the industry’s potential for future growth, such as through expansion plans, as well as the healthy earnings growth it has enjoyed over the last couple of years. He adds there is possibility that the stocks’ valuations – which are currently at multi-year highs – may continue to be supported by earnings growth and their defensive nature amid an uncertain economic landscape.
To continue reading,
Sign in to access this Premium article.
Subscription entitlements:
Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories
- IHH Healthcare’s 3QFY2024 patmi remains flat at RM534 mil
- Buying into China stimulus Is ‘painful trade’, Lombard Odier says
- Raffles Medical Group chairman ups stake to 55.592%